Cargando…

Dichloridobis[3-(4-meth­oxy­phen­yl)-2-methyl-5-(piperidin-1-yl)-2,3-di­hydro-1,2,4-oxa­diazole-κN (4)]platinum(II)

In title compound, [PtCl(2)(C(15)H(21)N(3)O(2))(2)], the Pt(II) cation, located on an inversion center, is coordinated by two Cl(−) anions and two 3-(4-meth­oxy­phen­yl)-2-methyl-5-(piperidin-1-yl)-2,3-di­hydro-1,2,4-oxa­diazole ligands in a distorted Cl(2)N(2) square-planar geometry. The di­hydro­o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kritchenkov, Andreii S., Lavnevich, Leonid V., Starova, Galina L., Bokach, Nadezhda A., Kalibabchuk, Valentina A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793679/
https://www.ncbi.nlm.nih.gov/pubmed/24109266
http://dx.doi.org/10.1107/S1600536813018059
_version_ 1782287089965989888
author Kritchenkov, Andreii S.
Lavnevich, Leonid V.
Starova, Galina L.
Bokach, Nadezhda A.
Kalibabchuk, Valentina A.
author_facet Kritchenkov, Andreii S.
Lavnevich, Leonid V.
Starova, Galina L.
Bokach, Nadezhda A.
Kalibabchuk, Valentina A.
author_sort Kritchenkov, Andreii S.
collection PubMed
description In title compound, [PtCl(2)(C(15)H(21)N(3)O(2))(2)], the Pt(II) cation, located on an inversion center, is coordinated by two Cl(−) anions and two 3-(4-meth­oxy­phen­yl)-2-methyl-5-(piperidin-1-yl)-2,3-di­hydro-1,2,4-oxa­diazole ligands in a distorted Cl(2)N(2) square-planar geometry. The di­hydro­oxa­diazole and piperidine rings display envelope (with the non-coordinating N atom as the flap atom) and chair conformations, respectively. In the crystal, weak C—H⋯Cl hydrogen bonds link the mol­ecules into supra­molecular chains running along the b axis. The piperidine ring is disordered over two positions with the occupancy ratio of 0.528 (4):0.472 (4).
format Online
Article
Text
id pubmed-3793679
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-37936792013-10-09 Dichloridobis[3-(4-meth­oxy­phen­yl)-2-methyl-5-(piperidin-1-yl)-2,3-di­hydro-1,2,4-oxa­diazole-κN (4)]platinum(II) Kritchenkov, Andreii S. Lavnevich, Leonid V. Starova, Galina L. Bokach, Nadezhda A. Kalibabchuk, Valentina A. Acta Crystallogr Sect E Struct Rep Online Metal-Organic Papers In title compound, [PtCl(2)(C(15)H(21)N(3)O(2))(2)], the Pt(II) cation, located on an inversion center, is coordinated by two Cl(−) anions and two 3-(4-meth­oxy­phen­yl)-2-methyl-5-(piperidin-1-yl)-2,3-di­hydro-1,2,4-oxa­diazole ligands in a distorted Cl(2)N(2) square-planar geometry. The di­hydro­oxa­diazole and piperidine rings display envelope (with the non-coordinating N atom as the flap atom) and chair conformations, respectively. In the crystal, weak C—H⋯Cl hydrogen bonds link the mol­ecules into supra­molecular chains running along the b axis. The piperidine ring is disordered over two positions with the occupancy ratio of 0.528 (4):0.472 (4). International Union of Crystallography 2013-07-06 /pmc/articles/PMC3793679/ /pubmed/24109266 http://dx.doi.org/10.1107/S1600536813018059 Text en © Kritchenkov et al. 2013 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Metal-Organic Papers
Kritchenkov, Andreii S.
Lavnevich, Leonid V.
Starova, Galina L.
Bokach, Nadezhda A.
Kalibabchuk, Valentina A.
Dichloridobis[3-(4-meth­oxy­phen­yl)-2-methyl-5-(piperidin-1-yl)-2,3-di­hydro-1,2,4-oxa­diazole-κN (4)]platinum(II)
title Dichloridobis[3-(4-meth­oxy­phen­yl)-2-methyl-5-(piperidin-1-yl)-2,3-di­hydro-1,2,4-oxa­diazole-κN (4)]platinum(II)
title_full Dichloridobis[3-(4-meth­oxy­phen­yl)-2-methyl-5-(piperidin-1-yl)-2,3-di­hydro-1,2,4-oxa­diazole-κN (4)]platinum(II)
title_fullStr Dichloridobis[3-(4-meth­oxy­phen­yl)-2-methyl-5-(piperidin-1-yl)-2,3-di­hydro-1,2,4-oxa­diazole-κN (4)]platinum(II)
title_full_unstemmed Dichloridobis[3-(4-meth­oxy­phen­yl)-2-methyl-5-(piperidin-1-yl)-2,3-di­hydro-1,2,4-oxa­diazole-κN (4)]platinum(II)
title_short Dichloridobis[3-(4-meth­oxy­phen­yl)-2-methyl-5-(piperidin-1-yl)-2,3-di­hydro-1,2,4-oxa­diazole-κN (4)]platinum(II)
title_sort dichloridobis[3-(4-meth­oxy­phen­yl)-2-methyl-5-(piperidin-1-yl)-2,3-di­hydro-1,2,4-oxa­diazole-κn (4)]platinum(ii)
topic Metal-Organic Papers
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3793679/
https://www.ncbi.nlm.nih.gov/pubmed/24109266
http://dx.doi.org/10.1107/S1600536813018059
work_keys_str_mv AT kritchenkovandreiis dichloridobis34methoxyphenyl2methyl5piperidin1yl23dihydro124oxadiazolekn4platinumii
AT lavnevichleonidv dichloridobis34methoxyphenyl2methyl5piperidin1yl23dihydro124oxadiazolekn4platinumii
AT starovagalinal dichloridobis34methoxyphenyl2methyl5piperidin1yl23dihydro124oxadiazolekn4platinumii
AT bokachnadezhdaa dichloridobis34methoxyphenyl2methyl5piperidin1yl23dihydro124oxadiazolekn4platinumii
AT kalibabchukvalentinaa dichloridobis34methoxyphenyl2methyl5piperidin1yl23dihydro124oxadiazolekn4platinumii